Clarity and control over business processes is a critical capability for every organization. None more so than global medical device manufacturer Karl Storz, where the effectiveness of their processes impacts patient outcomes. With Celonis Process Management, they’re finally able to put their processes under the knife.
Context: A vital commitment to process excellence
Process excellence is in global medtech manufacturer Karl Storz’s DNA. Etienne Kneschke, Executive Director Global Business Process Management, literally wrote a book about it. Co-authored with Simon Geisenberger, Mission Possible: The Process Excellence Enterprise discusses why enterprises need to manage processes and process-related information through a single source if they are to achieve process excellence.
A passionate advocate of business process management (BPM), with more than 12 years of experience, Kneschke led the company’s implementation of the Celonis platform in 2019. With a holistic approach using Symbio process management and Celonis Process Intelligence in conjunction, Karl Storz eventually switched to Celonis Process Management when the two companies joined forces in 2023. Kneschke continues to expand new use cases, moving from just streamlining processes and making them more efficient to helping to meet quality criteria.
As the market leader in manufacturing endoscopy equipment, integrated operating room solutions and robotic surgery, quality control is one of Karl Storz’s most important areas of business value. In their industry, patient safety and care is on the line when it comes to the quality of products and business processes. End-to-end process optimization is a lifeline for maintaining consistent, high-quality service levels.